Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven condition RAPT seeks to develop a differentiated anti-IgE therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback